SEC Form 4 · accession 0001179110-18-002981
Traws Pharma, Inc. · TRAW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ramesh Kumar
Officer — President and CEO · Director
Period of report
Feb 23, 2018
Accepted (ET)
Feb 27, 2018 · 5:26 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001130598
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to purchase)F1 | $1.09 | Feb 23, 2018 | A | 73,220 | A | Feb 23, 2018 | Feb 23, 2028 | Common Stock | 73,220 | 73,220 | D |
Explanation of responses
- F1This option grant was made in lieu of cash payment for a portion of Dr. Kumar's year-end bonus. The options vest immediately.